Results 181 to 190 of about 19,507 (228)
Some of the next articles are maybe not open access.
JAMA: The Journal of the American Medical Association, 1979
THERE is a general but strongly held view that, after drugs are marketed, additional epidemiologic information is needed on their clinical effects, particularly adverse effects. This notion is based soundly on the limited size and scope of the clinical experience with a drug before marketing.
openaire +1 more source
THERE is a general but strongly held view that, after drugs are marketed, additional epidemiologic information is needed on their clinical effects, particularly adverse effects. This notion is based soundly on the limited size and scope of the clinical experience with a drug before marketing.
openaire +1 more source
Techniques of Postmarketing Surveillance
Medical Toxicology, 1986While there are many systems available for postmarketing surveillance today, none is ideal for every situation. Recent progress has been made through computerised data bases which allows for rapid identification of patients with diseases or drugs of interest. Careful planning, with attention to the relative strengths and weaknesses of each, will permit
J L, Carson, B L, Strom
openaire +2 more sources
Assessing risk in postmarketing surveillance
Journal of Biopharmaceutical Statistics, 1991We need to find some way to assess the probability of risk for individuals taking medications for a prolonged period of time either singly or, as is usually more likely, in combinations. It is not possible to perform detailed, controlled studies for all combinations of drugs, not even those most commonly administered.
P B, Cerrito, J C, Cerrito
openaire +2 more sources
The Canadian journal of hospital pharmacy, 1987
Postmarketing surveillance (PMS) studies allow for the systematic and comprehensive monitoring of the beneficial and harmful effects of prescription drugs as well as their usage patterns. The objectives of PMS are to assess the uses and effects of new drugs under conditions of customary clinical use.
openaire +1 more source
Postmarketing surveillance (PMS) studies allow for the systematic and comprehensive monitoring of the beneficial and harmful effects of prescription drugs as well as their usage patterns. The objectives of PMS are to assess the uses and effects of new drugs under conditions of customary clinical use.
openaire +1 more source
Cefmetazole postmarketing surveillance in Japan
Journal of Antimicrobial Chemotherapy, 1989The Sankyo Company Ltd had conducted a postmarketing surveillance programme on cefmetazole sodium since its marketing introduction in Japan. Two data collection approaches were used: a survey in which participating physicians provided complete information on all their patients who received cefmetazole for treatment of infection, and two voluntary ...
openaire +2 more sources
Drug Postmarketing Studies—Reply
JAMA, 2013Kevin, Fain, G Caleb, Alexander
openaire +2 more sources
Postmarketing Surveillance (PMS)
1985The term postmarketing surveillance should convey the meaning that the use of a drug after marketing is surveyed both for efficacy and safety; however, as the term is currently used, the emphasis is on safety rather than efficacy. One of the reasons for the lack of emphasis on efficacy has been the fact that the originating pharmaceutical company will ...
openaire +1 more source